Similar articles

• Clinical implications. In vitro resistance of E coli to TMP/SMX.

  [No authors listed] [No authors listed] Postgrad Med. 2001 Aug;110(2 Suppl):11-5; discussion 26-7. doi: 10.3810/pgm.08.2001.suppl15.82. Postgrad Med. 2001. PMID: 19667571 No abstract available.
• Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?

  Miller LG, Mehrotra R, Tang AW. Miller LG, et al. Int J Antimicrob Agents. 2007 May;29(5):605-7. doi: 10.1016/j.ijantimicag.2006.11.021. Epub 2007 Feb 12. Int J Antimicrob Agents. 2007. PMID: 17293087 No abstract available.
• Urinary tract infection.

  Hoey R, Probst F. Hoey R, et al. N Engl J Med. 2003 Oct 23;349(17):1674-6; author reply 1674-6. N Engl J Med. 2003. PMID: 14575059 No abstract available.
• Urinary tract infection: traditional pharmacologic therapies.

  Nicolle LE. Nicolle LE. Dis Mon. 2003 Feb;49(2):111-28. doi: 10.1067/mda.2003.11. Dis Mon. 2003. PMID: 12601341 Review.
• Clinical practice. Acute uncomplicated urinary tract infection in women.

  Fihn SD. Fihn SD. N Engl J Med. 2003 Jul 17;349(3):259-66. doi: 10.1056/NEJMcp030027. N Engl J Med. 2003. PMID: 12867610 Review. No abstract available.